<?xml version='1.0'?>
<!DOCTYPE art SYSTEM 'http://www.biomedcentral.com/xml/article.dtd'>
<art>
<ui>1750-9378-7-S1-O17</ui>
<ji>1750-9378</ji>
<fm>
<dochead>Oral presentation</dochead>
<bibl>
<title>
<p>CD4 regulatory T cells Control CD8 T cell responses to human Herpesvirus 8 lytic and latency proteins</p>
</title>
<aug>
<au ca="yes" id="A1"><snm>Lepone</snm><fnm>Lauren</fnm><insr iid="I1"/><email>lml33@pitt.edu</email></au>
<au id="A2"><snm>Rappocciolo</snm><fnm>Giovanna</fnm><insr iid="I1"/></au>
<au id="A3"><snm>Piazza</snm><fnm>Paolo</fnm><insr iid="I1"/></au>
<au id="A4"><snm>Jais</snm><fnm>Mariel</fnm><insr iid="I1"/></au>
<au id="A5"><snm>Jenkins</snm><mi>J</mi><fnm>Frank</fnm><insr iid="I1"/></au>
<au id="A6"><snm>Rinaldo</snm><mi>R</mi><fnm>Charles</fnm><insr iid="I1"/></au>
</aug>
<insg>
<ins id="I1"><p>Department of Infectious Diseases and Microbiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA</p></ins>
</insg>
<source>Infectious Agents and Cancer</source>


<supplement><title><p>Proceedings of the 13th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI)</p></title><editor>Geraldina Dominguez</editor><note>Meeting abstracts</note></supplement><conference><title><p>13th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI)</p></title><location>Bethesda, MD, USA</location><date-range>7-8 November 2011</date-range><url>http://www.capconcorp.com/meeting/2011/13thICMAOI/index.asp</url></conference><issn>1750-9378</issn>
<pubdate>2012</pubdate>
<volume>7</volume>
<issue>Suppl 1</issue>
<fpage>O17</fpage>
<url>http://www.infectagentscancer.com/content/7/S1/O17</url>
<xrefbib><pubid idtype="doi">10.1186/1750-9378-7-S1-O17</pubid></xrefbib></bibl>
<history><pub><date><day>19</day><month>4</month><year>2012</year></date></pub></history>
<cpyrt><year>2012</year><collab>Lepone et al; licensee BioMed Central Ltd.</collab><note>This is an open access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</note></cpyrt>
</fm>
<bdy>
<sec>
<st>
<p>Objectives</p>
</st>
<p>CD8 T cells are considered to play an important role in controlling human herpesvirus 8 (HHV-8/KSHV) infection. However, these T cell responses are non-robust compared to other herpesviruses, suggesting that they are under tight regulatory control.</p>
</sec>
<sec>
<st>
<p>Methods</p>
</st>
<p>Longitudinal PBMC samples were obtained from subjects with various outcomes of HHV-8 infection over many years in the Multicenter AIDS Cohort Study. The PBMC were tested by HLA A*0201 multimer staining specific for memory CD8 T cell epitopes of viral lytic and latency proteins, and polyfunctional flow cytometry to detect HHV8-specific, polyfunctional CD8 T cell populations. The effect of Treg was examined by depleting CD4<sup>+</sup>CD25<sup>Hi</sup> cells.</p>
</sec>
<sec>
<st>
<p>Results</p>
</st>
<p>Direct staining of PBMC with multimer MHC I complexes showed a relatively high frequency of circulating, HHV-8 lytic and latency antigen-specific CD8 T cells, but low anti-HHV-8 T cell polyfunctional reactivity. Removal of Treg enhanced T cell responses to these HHV-8 epitopes. The frequency of T cells specific for HHV-8 lytic antigens was greater than for latent antigens, and this effect was greater when Treg were removed. Numbers of HHV-8 specific effector memory CD8 T cells increased and terminally differentiated memory CD8 T cells decreased over many years of HHV-8 infection. We are currently assessing anti-HHV-8 T cell and Treg activity in relation to development of KS.</p>
</sec>
<sec>
<st>
<p>Conclusions</p>
</st>
<p>We show for the first time that Treg suppress CD8 T cell responses to HHV-8 lytic and latency antigens, effectively masking more robust, underlying anti-HHV-8 T cell responses. The involvement of CD8 T cells and Treg in control of HHV-8 infection has important implications for development of vaccines to prevent KS.</p>
</sec>
</bdy>
</art>